Gilead Sciences Inc sell Traumtanz
Start price
27.10.19
/
50%
€57.14
Target price
03.02.20
€50.00
Performance (%)
6.00%
End price
03.02.20
€60.57
Summary
This prediction ended on 03.02.20 with a price of €60.57. With a performance of 6.00%, the SELL prediction by Traumtanz for Gilead Sciences Inc was trending in the wrong direction Dividends of €0.57 are taken into consideration when calculating the performance. Traumtanz has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Gilead Sciences Inc | -1.570% | -1.570% | -16.300% | 10.280% |
iShares Core DAX® | -0.922% | -1.993% | 13.399% | 16.075% |
iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% | 46.938% |
iShares Nikkei 225® | 2.224% | -5.187% | 20.497% | 4.643% |
iShares S&P 500 | -0.026% | -0.918% | 30.410% | 42.418% |
According to Traumtanz what are the pros and cons of Gilead Sciences Inc for the foreseeable future?
Pros
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Strong uniques
Small Risks for its business
Could be very worthwhile Investment >20% year
Cons
Comments by Traumtanz for this prediction
In the thread Gilead Sciences Inc diskutieren
Sell mit Kursziel 50,0
dafür dass hier nix passiert, gibt es viele die immer noch den Kauf empfehlen!?
ok Dividende ist ein Punkt für eine Aktie, die wenig Kursgewinn zeigt, aber Gilead fällt nach wie vor in langsamen Tempo immer wieder ein bisschen weiter....wartert ihr auf den Turnaround?
kidnah1 schrieb:
@Traumtanz
ich denke sie verläuft seit 2017 quer.
Seit August 2019 haben wir auch nur noch höhere Tiefs bekommen was an eine Trendumkehr denken lässt.
Gelingt es Gilead wieder Phantasie ins Geschäft zu bringen wird der Titel auch wieder normale Bewertungen von Biotech Unternehmen annehmen.
ich denke sie verläuft seit 2017 quer.
Seit August 2019 haben wir auch nur noch höhere Tiefs bekommen was an eine Trendumkehr denken lässt.
Gelingt es Gilead wieder Phantasie ins Geschäft zu bringen wird der Titel auch wieder normale Bewertungen von Biotech Unternehmen annehmen.
wenn das bei 54€ die Bodenbildung war, dann dauert das aber noch...
ich bin anscheindend die Einzige hier, die nicht an Gilead glaubt ;-)
In the thread Trading Gilead Sciences Inc
Sell beendet
Stopped prediction by Traumtanz for Gilead Sciences Inc
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€56.02
06.04.21
06.04.21
€60.00
06.04.22
06.04.22
3.82%
01.07.21
01.07.21
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€48.01
18.12.20
18.12.20
€45.00
-1.78%
23.12.20
23.12.20
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€51.30
14.11.20
14.11.20
-
14.11.21
14.11.21
-1.75%
23.11.20
23.11.20
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€50.60
13.11.20
13.11.20
€52.00
1.38%
14.11.20
14.11.20
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€50.00
09.11.20
09.11.20
€55.00
2.66%
10.11.20
10.11.20
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€49.75
31.10.20
31.10.20
-
04.11.21
04.11.21
0.53%
09.11.20
09.11.20
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€54.61
23.10.20
23.10.20
€55.00
31.10.20
31.10.20
-8.91%
31.10.20
31.10.20
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€51.42
20.10.20
20.10.20
€50.00
22.10.20
22.10.20
-1.26%
22.10.20
22.10.20
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€55.32
26.08.20
26.08.20
€50.00
08.10.20
08.10.20
-2.68%
08.10.20
08.10.20
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€55.59
19.08.20
19.08.20
€52.00
24.08.20
24.08.20
0.76%
24.08.20
24.08.20
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€67.00
20.06.20
20.06.20
€55.00
03.08.20
03.08.20
-10.91%
03.08.20
03.08.20
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€66.80
20.05.20
20.05.20
€60.00
25.05.20
25.05.20
4.09%
25.05.20
25.05.20
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€77.45
30.04.20
30.04.20
€85.00
04.05.20
04.05.20
-5.28%
04.05.20
04.05.20
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€74.99
04.04.20
04.04.20
-
18.04.20
18.04.20
5.08%
18.04.20
18.04.20
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€70.00
21.03.20
21.03.20
-
04.04.20
04.04.20
3.16%
04.04.20
04.04.20
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€76.81
19.03.20
19.03.20
€85.00
19.03.20
19.03.20
-3.91%
19.03.20
19.03.20
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€64.45
11.03.20
11.03.20
€55.00
11.03.20
11.03.20
0.51%
11.03.20
11.03.20
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€72.20
07.03.20
07.03.20
-
10.03.20
10.03.20
-13.56%
10.03.20
10.03.20
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€62.32
28.02.20
28.02.20
€58.00
07.03.20
07.03.20
9.27%
07.03.20
07.03.20
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€59.93
13.06.19
13.06.19
€45.10
07.08.19
07.08.19
-3.22%
07.08.19
07.08.19
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€58.18
13.05.19
13.05.19
€45.10
13.06.19
13.06.19
4.48%
13.06.19
13.06.19
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€55.99
25.04.19
25.04.19
€45.10
25.04.19
25.04.19
3.20%
25.04.19
25.04.19
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€77.35
03.02.16
03.02.16
€90.00
09.02.17
09.02.17
-18.07%
09.02.17
09.02.17
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model